Review Article
Improving Prediction Algorithms for Cardiometabolic Risk in Children and Adolescents
Table 1
Cardiometabolic risk scores developed for children and adolescents.
| | Andersen and Haraldsdottir 1993 [32] | ADA 2000 [22, 36] | Rodríguez-Morán et al. 2004 [23] | McMahan et al. 2005 [21] | Andersen et al. 2006 [33] | Reed et al. 2007 [18] | Brambilla et al. 2007 [19] Bueno et al. 2007 [20] | Andersen et al. 2010 [35] |
| | 203 | 66 | 965 | 2,575 | 1,732 | 242 | 153 | 210 | Age range (years) | 15–19 | 5–17 | 10–18 | 15–34 | 9–15 | 9–11 | 9–13 | 9-10 | Sex (% male) | 43 | 29 | N/A | N/A | 47 | 50 | 52 | 54 |
| Nationality or ethnicity | Danish | South Asian, British, and African Caribbean | Mexican | | Danish, Estonian, and Portuguese | Canadian | Spanish | Danish |
| Stratification, adjustment, or standardisation | Sex | Age and sex (for BMI) | Age and sex (for BMI, BP, and TG) | | Age, sex, and country | Age, sex | Sex (for obesity) | Sex |
| Exclusions | | | | | | | Nonobese | |
| Score name | Total risk score | T2D criteria | REGODCI | PDAY | Composite score | Healthy Heart Score | MIRACLE | Composite risk factor score |
| Risk factor included [Y = yes] |
| Age | | | | Y | | | | | Sex | | | | Y | | | | | BMI | | Y | Y | Y | | Y | Y | | | | | | | | | Y | | Skinfolds | Y | | | | Y | | | Y | | Y | | Y | | Y | Y | Y | Y | | Y | | Y | | | Y | Y | | | | Y | | Y | | | | | TC | Y | | | | | | | | | Y | | Y | Y | | | | | Non-HDL-C | | | | Y | | | | | TC:HDL-C | | | | | Y | | | Y | | Y | | Y | | Y | | | Y | | | | Y | | | | | | Dyslipidemia | | Y | | | | | | | Hyperglycemia | | | | Y | | | Y | | Insulin resistance | | | | | Y | | | Y | T2D | | | | | | | Y | | PCOS | | Y | | | | | | | Smoking | Y | | | Y | | | | | Fitness | | | | | Y | Y | | Y | PA | | | | | | Y | | | Family history of CVD/T2D/Hypertension/obesity | | Y | Y | | | | Y | | SGA | | | | | | | Y | | Birth weight | | | Y | | | | | | Ethnicity | | Y | | | | | Y | | Acanthosis nigricans | | Y | | | | | Y | |
|
|
MetS components are given in italics.
|